Z
Zahava Berkowitz
Researcher at Centers for Disease Control and Prevention
Publications - 60
Citations - 2637
Zahava Berkowitz is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Population & National Health Interview Survey. The author has an hindex of 26, co-authored 58 publications receiving 2375 citations.
Papers
More filters
Journal ArticleDOI
Melanoma survival in the United States, 1992 to 2005.
Lori A. Pollack,Jun Li,Zahava Berkowitz,Hannah K. Weir,Xiao-Cheng Wu,Umed A. Ajani,Donatus U. Ekwueme,Chunyu Li,Brian Pollack,Brian Pollack +9 more
TL;DR: Poorer survival from melanoma was observed among those given the diagnosis at late stage and older age, and this change was not clearly associated with a shift toward localized diagnosis.
Journal ArticleDOI
Beliefs, Risk Perceptions, and Gaps in Knowledge as Barriers to Colorectal Cancer Screening in Older Adults
TL;DR: To assess beliefs and perceptions of risk about colorectal cancer (CRC) and gaps in knowledge about screening in adults aged 65 to 89, a large number of people believe that they should be screened for CRC and perceptions about risk are questioned.
Journal ArticleDOI
Health-related behavior change after cancer: results of the American Cancer Society’s studies of cancer survivors (SCS)
TL;DR: Demographic, medical, and psychosocial variables were associated with both types of changes and cancer survivors were more likely to make positive than negative behavior changes after cancer.
Journal ArticleDOI
Information-seeking styles among cancer patients before and after treatment by demographics and use of information sources.
Christie R. Eheman,Zahava Berkowitz,Judith W. Lee,Supriya G. Mohile,Jason Q. Purnell,Elisa M. Rodriguez,Joseph A. Roscoe,David Johnson,Jeffrey J. Kirshner,Gary R. Morrow +9 more
TL;DR: The relationships between information-seeking style (active, moderately active, and passive styles) and demographics, cancer type, and health status for the pretreatment and posttreatment periods and overall are evaluated.
Journal ArticleDOI
Cervical Cancer Screening With Both Human Papillomavirus and Papanicolaou Testing vs Papanicolaou Testing Alone: What Screening Intervals Are Physicians Recommending?
TL;DR: A lower proportion of PCPs recommend extending screening intervals to 3 years with an HPV cotest than those screening with the Pap test alone, and physician specialty was strongly associated with guideline-consistent recommendations for the next Pap or HPV test.